19-41337556-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000660.7(TGFB1):​c.860+4327A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 152,034 control chromosomes in the GnomAD database, including 1,294 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1294 hom., cov: 31)

Consequence

TGFB1
NM_000660.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -4.68

Publications

26 publications found
Variant links:
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
  • Camurati-Engelmann disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • inflammatory bowel disease, immunodeficiency, and encephalopathy
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.255 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFB1NM_000660.7 linkc.860+4327A>G intron_variant Intron 5 of 6 ENST00000221930.6 NP_000651.3 P01137A0A499FJK2
TGFB1XM_011527242.3 linkc.863+4327A>G intron_variant Intron 5 of 6 XP_011525544.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFB1ENST00000221930.6 linkc.860+4327A>G intron_variant Intron 5 of 6 1 NM_000660.7 ENSP00000221930.4 A0A499FJK2
TGFB1ENST00000600196.2 linkc.712+4614A>G intron_variant Intron 4 of 5 5 ENSP00000504008.1 A0A7I2YQL8
TGFB1ENST00000677934.1 linkc.635-5275A>G intron_variant Intron 3 of 4 ENSP00000504769.1 A0A7I2V5Z9
TGFB1ENST00000598758.5 linkn.148+4327A>G intron_variant Intron 1 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.121
AC:
18379
AN:
151916
Hom.:
1285
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.175
Gnomad AMI
AF:
0.188
Gnomad AMR
AF:
0.0942
Gnomad ASJ
AF:
0.0912
Gnomad EAS
AF:
0.267
Gnomad SAS
AF:
0.0919
Gnomad FIN
AF:
0.0884
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.0906
Gnomad OTH
AF:
0.129
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.121
AC:
18433
AN:
152034
Hom.:
1294
Cov.:
31
AF XY:
0.120
AC XY:
8902
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.176
AC:
7291
AN:
41454
American (AMR)
AF:
0.0939
AC:
1433
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.0912
AC:
316
AN:
3466
East Asian (EAS)
AF:
0.267
AC:
1376
AN:
5162
South Asian (SAS)
AF:
0.0918
AC:
443
AN:
4828
European-Finnish (FIN)
AF:
0.0884
AC:
936
AN:
10588
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.0906
AC:
6160
AN:
67972
Other (OTH)
AF:
0.129
AC:
272
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
804
1609
2413
3218
4022
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.117
Hom.:
413
Bravo
AF:
0.126
Asia WGS
AF:
0.197
AC:
683
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.33
DANN
Benign
0.26
PhyloP100
-4.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11466345; hg19: chr19-41843461; API